Search
for
Sort by
Research 361–390 of 1000+
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Hair growth-modulation by adrenergic drugs
- Immune checkpoint inhibitor‐related alopecia: Insight into the pathophysiology utilizing non‐invasive diagnostic techniques
- Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
- Harnessing Milk-derived Extracellular Vesicles for Oral Drug Delivery and Therapeutic Application
- EFFECT OF PLASMATHERAPY ON THE IMMUNE STATUS OF PATIENTS WITH VITILIGO
- TNC+ fibroblasts involve in skin inflammation via neuro-immune and interacting with T cells
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- An Update on Drug-Induced Pigmentation
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Discovery of New Drug Therapies Based on the Study of Adverse Reactions
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Liposome-based drug delivery systems for skin wound healing: a promising drug delivery strategy
- The hair follicle as a neuro-immuno-endocrine organ: Implications in hair disorders and regenerative therapies
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- NUMERICAL DESCRIPTOR COMPUTATION OF ALOPECIA DRUGS USING COM – POLYNOMIAL
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Drug Repurposing Patent Applications July–September 2025
- Development and Invitro Evaluation of Solid Lipid Nano Particles Loaded Topical Gel Containing Combination of Drugs Used In The Better Therapy of Psoriasis
- Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Hypersensitivity Reactions to Anticoagulant Drugs
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study